# CV6 Therapeutics: An early stage drug development company

> CV6 Therapeutics is developing investigational therapies designed for combination use with established standards of care\.

Generated by Yoast SEO v27.5, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Home](https://cv6t.com/)
- [Clinical Trials](https://cv6t.com/clinical-trials/)
- [Programs](https://cv6t.com/programs/)
- [Udai Banerji, MD, PhD](https://cv6t.com/about/udai-banerji/)
- [Tess Barker, PhD](https://cv6t.com/about/tess-barker/)

## News
- [Op\-Ed: Science Is Not a Medicine\. Why Northern Ireland was the right place to build CV6 Therapeutics](https://cv6t.com/newsroom/robert-ladner-ph-d-op-ed-science-is-not-a-medicine-why-northern-ireland-was-the-right-place-to-build-cv6-therapeutics/): We looked for a place where the science would have the strongest opportunity to become a medicine\. More than a decade later,  as we are advancing through our Phase 1a trial, I remain convinced that we made the right choice\.
- [CV6 Therapeutics Appoints Dr\. Chris Takimoto to Board of Directors](https://cv6t.com/newsroom/cv6-therapeutics-appoints-dr-chris-takimoto-to-board-of-directors/): CV6 Therapeutics today announced the appointment of veteran oncology drug developer Dr\. Chris Takimoto to its Board of Directors as the company advances its lead program, CV6\-168, through Phase 1a clinical development\.
- [CV6 Therapeutics Contributes to Discussions on the Future of Oncology Innovation Across Ireland](https://cv6t.com/newsroom/cv6-therapeutics-contributes-to-discussions-on-the-future-of-oncology-innovation-across-ireland/): Dr\. Robert D\. Ladner, CEO and Founder of CV6 Therapeutics, was invited to join leading voices from industry, healthcare, academia, and government at two major oncology innovation events in Dublin to discuss opportunities to accelerate cancer research, clinical development, and patient access to new therapies\.
- [CV6 Therapeutics Joins QUBIS “Spin Out to Stand Out” Event at Queen’s University Belfast](https://cv6t.com/newsroom/cv6-therapeutics-joins-qubis-spin-out-to-stand-out-event-at-queens-university-belfast/): CV6 Therapeutics was proud to participate in “Spin Out to Stand Out,” a recent alumni and innovation event hosted by Queen's University Belfast and QUBIS on Wednesday, 29 April 2026, highlighting the strength of Northern Ireland’s growing entrepreneurial ecosystem\.
- [CV6 Therapeutics to Attend JP Morgan Week](https://cv6t.com/newsroom/cv6-therapeutics-to-attend-jp-morgan-week/): CV6 Therapeutics Inc\., CEO and Founder, Dr Robert Ladner will be attending JP Morgan Week, to be held on the 8th\-12th January at the Marriott Marquis in San Francisco, California, USA\.

## Programs
- [Oncology](https://cv6t.com/programs/oncology/): CV6 is advancing investigational therapies for cancers where standard treatments remain essential but resistance remains a major clinical challenge\.
- [Inflammatory Diseases](https://cv6t.com/programs/inflammatory-diseases/): CV6 is applying the same scientific approach to inflammatory diseases, including rheumatoid arthritis, where significant unmet medical needs remain\.

- [Pipeline](https://cv6t.com/programs/pipeline/): Lorem ipsum dolor sit amet consectetur\. In consectetur sollicitudin nibh elit iaculis mauris neque suspendisse\. Congue suscipit elementum dolor eros\.

## Careers
- [Test Career](https://cv6t.com/career/test-career/)
- [Test Job 2](https://cv6t.com/career/test-job-2/)

## Categories
- [Announcements](https://cv6t.com/newsroom-category/announcements/)
- [Press Releases](https://cv6t.com/newsroom-category/press-releases/)
- [Media \& Appearances](https://cv6t.com/newsroom-category/media-and-appearances/)
- [Op\-Ed](https://cv6t.com/newsroom-category/op-ed/)

## Optional
- [Sitemap index](https://cv6t.com/sitemap_index.xml)